Edition:
United Kingdom

People: Athene Holding Ltd (ATH.N)

ATH.N on New York Stock Exchange

42.33USD
17 Sep 2019
Change (% chg)

$-0.50 (-1.17%)
Prev Close
$42.83
Open
$42.47
Day's High
$42.71
Day's Low
$41.90
Volume
415,918
Avg. Vol
318,061
52-wk High
$53.88
52-wk Low
$36.07

Kvalheim, Grant 

Mr. Grant Kvalheim is Executive Vice President - Athene, Chief Executive Officer and President - Athene USA of the company. He has served as the Chief Executive Officer of Athene USA since June 2015 and served as our President from January 2011 until September 2015, served as the Chief Financial Officer from January 2011 until April 2013 and served as a director from January 2012 until February 2014. Mr. Kvalheim is responsible for the oversight of our U.S. operating companies with a focus on our retail annuity channel, including growth initiatives and new product development. Prior to joining our Company, Mr. Kvalheim was a senior executive of Barclays Capital (“Barclays”) from early 2001 to the end of 2007, becoming Co-President in September 2005. During his time at Barclays he converted a European cash investment grade business into a leading global cash and derivatives business across both securitized and non-securitized credit products, and significantly expanded Barclays’ investment banking platform. Prior to joining Barclays, Mr. Kvalheim held senior executive positions in the investment banks of Deutsche Bank and Merrill Lynch. Mr. Kvalheim has a Bachelor of Arts degree in economics from Claremont McKenna College and a Master of Business Administration in finance from the University of Chicago. He served on the board of directors of the Permal Silk Road Fund from June 2008 to November 2012. He currently serves on the board of directors of Mottahedeh & Co., Sol Health and United Way of Central Iowa.

Basic Compensation

Total Annual Compensation, USD 2,488,750
Restricted Stock Award, USD 482,377
Long-Term Incentive Plans, USD --
All Other, USD 352,595
Fiscal Year Total, USD 3,323,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 32,103 1,598,090.00